Radiotherapy (RT) is considered as a standard in the treatment of most solid cancers,
including glioblastoma, lung, breast, rectal, prostate, colorectal, cervical, esophageal, and …

Pancreatic cancer is an aggressive cancer with low survival rates. Genetic and epigenetic
dysregulation has been associated with the initiation and progression of pancreatic tumors …

Background Adriamycin (ADM) is one of the postoperative chemotherapy drugs for breast
cancer (BCa) patients. Circular RNAs have been shown to modulate ADM resistance in …

Platinum sensitivity is an important prognostic factor in patients with ovarian cancer.
Chromodomain-helicase-DNA-binding protein 4 (CHD4) is a core member of the …

Background The overall survival rate of patients with advanced ovarian cancer (OC) has
remained static for several decades. Advanced ovarian cancer is known for its poor …

Chromodomain helicase DNA binding protein 4 (CHD4), as a core component of the
nucleosome remodeling and deactetylase (NuRD) complex, participated in the inititation …

Colorectal cancer (CRC) has ranked first in terms of incidence in Taiwan. Surgical resection
combined with chemo-, radio-, or targeted-therapies are the main treatments for CRC …

Background The role of microsatellite instability (MSI) and prognosis for stage II–III colorectal
cancer (CRC) has been described, but the role of MSI in stage I and IV CRC is controversial …

Background. Preoperative chemoradiotherapy (pCRT) is a common and essential
therapeutic strategy for patients with locally advanced rectal cancer (LARC), but poor tumor …

Despite great efforts in improving existing therapies, the outcome of patients with advanced
radioresistant HPV-negative head and neck squamous cell carcinoma (HNSCC) remains …